We've found
184,457
clinical trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Anaplastic Thyroid Cancer Clinical Trial
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Post-Operative Pain Management Following Spine Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AVID100 in Advanced Epithelial Carcinomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma, Metastatic Clinical Trial
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Status: Enrolling,
Phase
II
Updated: 9/27/2017
Click here to add this to my saved trials
Endocrinology Clinical Trial
Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects
Status: Enrolling
Updated: 4/27/2017
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Saline Hypertonic in Preschoolers + CT
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
HSV Infection Clinical Trial
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HSV Infection Clinical Trial
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cognitive Function Clinical Trial
Pain Effect on Attention Using an Ipad Game App
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Anaplastic Thyroid Cancer Clinical Trial
Updated: 12/31/1969
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Updated: 12/31/1969
Post-Operative Pain Management Following Spine Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AVID100 in Advanced Epithelial Carcinomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma, Metastatic Clinical Trial
Updated: 9/27/2017
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Status: Enrolling,
Phase
II
Updated: 9/27/2017
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 4/27/2017
Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects
Status: Enrolling
Updated: 4/27/2017
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Updated: 12/31/1969
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Updated: 12/31/1969
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Updated: 12/31/1969
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Breast Cancer (IBC) Clinical Trial
Updated: 12/31/1969
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Saline Hypertonic in Preschoolers + CT
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
HSV Infection Clinical Trial
Updated: 12/31/1969
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HSV Infection Clinical Trial
Updated: 12/31/1969
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cognitive Function Clinical Trial
Updated: 12/31/1969
Pain Effect on Attention Using an Ipad Game App
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials